Trendy RNA tools for aging research

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 8, 2004, Pages 771-783

  Deocaris, Custer C ^a,b   Kaul, Sunil C ^a   Taira, Kazunari ^a,b   Wadhwa, Renu ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; RIBONUCLEASE P; RIBOZYME; RNA; RNA HELICASE; SMALL INTERFERING RNA; TRANSFER RNA;

AGING; CELL DIVISION; CELL PROLIFERATION; COMBINATORIAL LIBRARY; DNA SEQUENCE; ENTROPY; GENE FUNCTION; GENE MUTATION; GENE REPRESSION; GENE SILENCING; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; GENOMICS; HOMOLOGOUS RECOMBINATION; HUMAN; INTRON; LIFESPAN; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN RNA BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; REVIEW; RNA DEGRADATION; RNA INTERFERENCE; RNA SEQUENCE; RNA SPLICING; RNA STABILITY; RNA STRUCTURE; RNA SYNTHESIS; SENESCENCE; SPECIES DIFFERENCE; TELOMERE; ANIMAL; GENETIC PROCEDURES; PHYSIOLOGY;

AGING; ANIMALS; GENETIC TECHNIQUES; RNA;

EID: 4444347673     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (190)

1. Bengtson VL, Parrott TM, Burgess EO. Progress and pitfalls in gerontological theorizing. Gerontologist. 1996;36:768-772.
2. Pereira-Smith OM, Rookyard P, Echigo J, Smith JR. Genetics of cellular aging. In: Kaul SC, Wadhwa R, eds. Aging of Cells In and Outside the Body. Vol 2. Netherlands: Kluwer Academic Publishers; 2003:9-26.
3. Vijg J, Suh Y. Functional genomics of ageing. Mech Ageing Dev. 2003;124:3-8.
4. Troen BR. The biology of aging. Mt Sinai J Med. 2003;70:3-22.
5. Slagboom PE, Heijmans BT, Beekman M, et al. Genetics of human aging. The search for genes contributing to human longevity and diseases of the old. Ann N Y Acad Sci. 2000;908:50-63.
6. Arking R, Buck S, Novoseltev VN, Hwangbo DS, Lane M. Genomic plasticity, energy allocations, and the extended longevity phenotypes of Drosophila. Ageing Res Rev. 2002;1:209-228.
7. Munoz MJ. Longevity and heat stress regulation in Caenorhabditis elegans. Mech Ageing Dev. 2003;124:43-48.
8. Van Zant G, de Haan G. Genetic control of lifespan: studies from animal models. Expert Rev Mol Med. 1999;28:1-12.
9. Finch CE, Ruvkun G. The genetics of aging. Annu Rev Genomics Hum Genet. 2001;2:435-462.
10. Frederiksen H, Gaist D, Petersen HC, et al. Hand grip strength: a phenotype suitable for identifying genetic variants affecting midand late-life physical functioning. Genet Epidemiol. 2002;23: 110-122.
11. Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature. 2003;423:298-301.
12. Shen J, Loeb LA. Unwinding the molecular basis of the Wemer syndrome. Mech Ageing Dev. 2001;122:921-944.
13. Pereira-Smith OM, Ning Y. Molecular genetic studies of cellular senescence. Exp Gerontol. 1992;27:519-522.
14. Clark AJ, Ferrier P, Aslam S, et al. Proliferative lifespan is conserved after nuclear transfer. Nat Cell Biol. 2003;5:535-538.
15. Miyashita N, Shiga K, Yonai M, et al. Remarkable differences in telomere lengths among cloned cattle derived from different cell types. Biol Reprod. 2002;66:1649-1655.
16. Hayflick L, Moorehead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585-621.
17. Londono-Vallejo JA, Der-Sarkissian H, Cazes L, Bacchetti S, Reddel RR. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res. 2004;64:2324-2327.
18. Toouli CD, Reddel RR. Telomeres and cellular aging. In: Kaul SC, Wadhwa R, eds. Aging of Cells In and Outside the Body. Vol 2. Netherlands: Kluwer Academic Publishers; 2003:171-205.
19. Serrano AL, Andres V. Telomeres and cardiovascular disease: does size matter? Circ Res. 2004;94:575-584.
20. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest. 2004;113:160-168.
21. Ahmed A, Tollefsbol T. Telomeres and telomerase: basic science implications for aging. J Am Geriatr Soc. 2001;49:1105-1109.
22. Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol. 2002;41:29-40.
23. von Zglinicki T. Telomeres: influencing the rate of aging. Ann N Y Acad Sci. 1998;854:318-327.
24. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-460.
25. Harley CB, Kim NW, Prowse KR, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol. 1994;59:307-315.
26. Von Zglinicki T. Replicative senescence and the art of counting. Exp Gerontol. 2003;38:1259-1264.
27. Ben-Porath I, Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest. 2004;113:8-13.
28. Haussmann MF, Winkler DW, O'Reilly KM, Huntington CE, Nisbet IC, Vleck CM. Telomeres shorten more slowly in long-lived birds and mammals than in short-lived ones. Proc R Soc Lond B Biol Sci. 2003; 270:1387-1392.
29. Cheong C, Hong KU, Lee HW. Mouse models for telomere and telomerase biology. Exp Mol Med. 2003;35:141-153.
30. Takubo K, Izumiyama-Shimomura N, Honma N, et al. Telomere lengths are characteristic in each human individual. Exp Gerontol. 2002;37:523-531.
31. Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell. 1983;35:849-857.
32. Kruger K, Grabowski P, Zaug A, Sands J, Gottschling D, Cech T. Autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell. 1982;31:147-157.
33. James KD, Ellington AD. The search for missing links between self-replicating nucleic acids and the RNA world. Orig Life Evol Biosph. 1995;25:515-530.
34. Kumar PK, Ellington AD. Artificial evolution and natural ribozymes. Faseb J. 1995;9:1183-1195.
35. Long MB, Jones JP III, Sullenger BA, Byun J. Ribozyme-mediated revision of RNA and DNA. J Clin Invest. 2003;112:312-318.
36. Staddon JH, Bryan EM, Manias DA, Dunny GM. Conserved target for group II intron insertion in relaxase genes of conjugative elements of gram-positive bacteria. J Bacterial. 2004;186:2393-2401.
37. Byun J, Lan N, Long M, Sullenger BA. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes. RNA. 2003;9: 1254-1263.
38. Zou H, Chan K, Trang P, Liu F. General design and construction of RNase P ribozymes for gene-targeting applications. Methods Mol Biol. 2004;252:385-398.
39. Raj SM, Liu F. Engineering of RNase P ribozyme for gene-targeting applications. Gene. 2003;313:59-69.
40. Cobaleda C, Sanchez-Garcia I. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. Blood. 2000;95:731-737.
41. Hnatyszyn H, Spruill G, Young A, Seivright R, Kraus G. Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis. Gene Ther. 2001;8:1863-1871.
42. Flores R, Navarro JA, de la Pena M, Navarro B, Ambros S, Vera A. Viroids with hammerhead ribozymes: some unique structural and functional aspects with respect to other members of the group. Biol Chem. 1999;380:849-854.
43. Cremisi F, Scarabino D, Carluccio MA, Salvadori P, Barsacchi G. A new ribozyme: a catalytic activity in search of a function. Proc Natl Acad Sci U S A. 1992;89:1651-1655.
44. Vazquez-Tello A, Castan P, Moreno R, Smith JM, Berenguer J, Cedergren R. Efficient trans-cleavage by the Schistosoma mansoni SMalphal hammerhead ribozyme in the extreme thermophile Thermus thermophilus. Nucleic Acids Res. 2002;30:1606-1612.
45. Rojas AA, Vazquez-Tello A, Ferbyre G, et al. Hammerhead-mediating processing of satellite pDo500 family transcripts from Dolichopoda cave crickets. Nucleic Acids Res. 1998;28:4037-4043.
46. Kato Y, Taira K. Chemistry of ribozyme-catalyzed reaction. Recent Res Dev Organic Chem. 2002;6:407-420.
47. Scott WG. Biophysical and biochemical investigations of RNA catalysis in the hammerhead ribozyme. Q Rev Biophys. 1999;32: 241-284.
48. Murray JB, Seyhan AA, Walter NG, Burke JM, Scott WG. The hammerhead, hairpin and VS ribozymes are catalytically proficient in monovalent cations alone. Chem Biol. 1998;5:587-595.
49. Kikuchi Y, Sasaki N. Site-specific cleavage of natural mRNA sequences by newly designed hairpin catalytic RNAs. Nucleic Acids Res. 1991;19:6751-6755.
50. Shippy R, Lockner R, Farnsworth M, Hampel A. The hairpin ribozyme. Discovery, mechanism, and development for gene therapy. Mol Biotechnol. 1999;12:117-129.
51. Esteban JA, Walter NG, Kotzorek G, Heckman JE, Burke JM. Structural basis for heterogeneous kinetics: reengineering the hairpin ribozyme. Proc Natl Acad Sci U S A. 1998;95:6091-6096.
52. Fedor MJ. Structure and function of the hairpin ribozyme. J Mol Biol. 2000;297:269-291.
53. Ferre-D'amare AR, Rupert PB. The hairpin ribozyme: from crystal structure to function. Biochem Soc Trans. 2002;30:1105-1109.
54. Jeng KS, Su PY, Lai MM. Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol. 1996;70: 4205-4209.
55. Been MD, Wickham GS. Self-cleaving ribozymes of hepatitis delta virus RNA. Eur J Biochem. 1997;247:741-753.
56. Sheng J, Al-Anouti F, Ananvoranich S. Engineered delta ribozymes can simultaneously knock down the expression of the genes encoding uracil phosphoribosyltransferase and hypoxanthine-xanthine-guanine phosphoribosyltransferase in Toxoplasma gondii. Int J Parasitol. 2004;34:253-263.
57. Yamanaka R, Xanthopoulos KG. Development of improved Sindbis virus-based DNA expression vector. DNA Cell Biol. 2004; 23:75-80.
58. Jeong S, Sefcikova J, Tinsley RA, Rueda D, Walter NG. Trans-acting hepatitis delta virus ribozyme: catalytic core and global structure are dependent on the 5′ substrate sequence. Biochemistry. 2003;42:7727-7740.
59. Saville BJ, Collins RA. RNA-mediated ligation of self-cleavage products of a Neurospora mitochondrial plasmid transcript. Proc Natl Acad Sci USA. 1991;88:8826-8830.
60. Lilley DM. The Varkud satellite ribozyme. RNA. 2004;10: 151-158.
61. Beattie TL, Collins RA. Identification of functional domains in the self-cleaving Neurospora VS ribozyme using damage selection. J Mol Biol. 1997;267:830-840.
62. Andersen AA, Collins RA. Intramolecular secondary structure rearrangement by the kissing interaction of the Neurospora VS ribozyme. Proc Natl Acad Sci U S A. 2001;98:7730-7735.
63. Samarsky D, Ferbeyre G, Bertrand E. Expressing active ribozymes in cells. Curr Issues Mol Biol. 2000;2:87-93.
64. Amarzguioui M, Brede G, Babaie E, Grotli M, Sproat B, Prydz H. Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes. Nucleic Acids Res. 2000;28:4113-4124.
65. Breaker RR. Engineered allosteric ribozymes as biosensor components. Curr Opin Biotechnol. 2002;13:31-39.
66. Koizumi M, Soukup GA, Kerr JN, Breaker RR. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP. Nat Struct Biol. 1999;6:1062-1071.
67. Koizumi M, Kerr JN, Soukup GA, Breaker RR. Allosteric ribozymes sensitive to the second messengers cAMP and cGMP. Nucleic Acids Symp Ser. 1999;42:275-276.
68. Tang J, Breaker RR. Mechanism for allosteric inhibition of an ATP-sensitive ribozyme. Nucleic Acids Res. 1998;26:4214-4221.
69. Sekella PT, Rueda D, Walter NG. A biosensor for theophylline based on fluorescence detection of ligand-induced hammerhead ribozyme cleavage. Rna. 2002;8:1242-1252.
70. Kuwabara T, Warashina M, Nakayama A, Ohkawa J, Taira K. tRNAVal-heterodimeric maxizymes with high potential as gene inactivating agents: simultaneous cleavage at two sites in HIV-1 Tat mRNA in cultured cells. Proc Natl Acad Sci U S A. 1999;96: 1886-1891.
71. Kuwabara T, Warashina M, Tanabe T, Tani K, Asano S, Taira K. A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo. Mol Cell. 1998;2:617-627.
72. Kong XJ, Lin JS, Song YH, Shen X, Jin YX. [Inhibition of mutant p53 in hepatocellular carcinoma cells by hammerhead ribozyme.] Zhonghua Gan Zang Bing Za Zhi. 2003;11:722-724.
73. Bertrand EL, Rossi JJ. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J. 1994;13:2904-2912.
74. Lin SS, Chang SC, Wang YH, Sun CY, Chang MF. Specific interaction between the hepatitis delta virus RNA and glyceraldehyde 3-phosphate dehydrogenase: an enhancement on ribozyme catalysis. Virology. 2000;271:46-57.
75. Herschlag D, Khosla M, Tsuchihashi Z, Karpel RL. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 1994;13:2913-2924.
76. Warashina M, Kuwabara T, Kato Y, Sano M, Taira K. RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA. Proc Natl Acad Sci U S A. 2001;98: 5572-5577.
77. Takagi Y, Suyama E, Kawasaki H, Miyagishi M, Taira K. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries. Biochem Soc Trans. 2002;30:1145-1149.
78. Wadhwa R, Kaul SC, Mitsui Y. Cellular mortality to immortalization: mortalin. Cell Struct Funct. 1994;19:1-10.
79. Wadhwa R, Ando H, Kawasaki H, Taira K, Kaul SC. Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes. EMBO Rep. 2003;4:595-601.
80. Kanazawa Y, Ohkawa K, Ueda K, et al. Hammerhead ribozymemediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem Biophys Res Commun. 1996; 225:570-576.
81. Yokoyama Y, Takahashi Y, Shinohara A, et al. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res. 1998;58:5406-5410.
82. Folini M, Colella G, Villa R, Lualdi S, Daidone MG, Zaffaroni N. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells. J Invest Dermatol. 2000;114:259-267.
83. Ludwig A, Saretzki G, Holm PS, et al. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res. 2001;61:3053-3061.
84. Saretzki G, Ludwig A, von Zglinicki T, Runnebaum IB. Ribozymemediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Cancer Gene Ther. 2001; 8:827-834.
85. Zhao YH, Chen XY, J RA. [Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells.] Ai Zheng. 2004;23: 50-55.
86. Mollano AV, Martin JA, Buckwalter JA. Chondrocyte senescence and telomere regulation: implications in cartilage aging and cancer (a brief review). Iowa Orthop J. 2002;22:1-7.
87. Rowe-Rendleman C, Glickman RD. Possible therapy for age-related macular degeneration using human telomerase. Brain Res Bull. 2004; 62:549-553.
88. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004;94:514-524.
89. Lieber A, Strauss M. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol. 1995; 15:540-551.
90. zu Putlitz J, Yu Q, Burke JM, Wands JR. Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus. J Virol. 1999;73:5381-5387.
91. Bramlage B, Luzi E, Eckstein F. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture. Nucleic Acids Res. 2000;28:4059-4067.
92. Kruger M, Beger C, Li QX, et al. Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach. Proc Natl Acad Sci U S A. 2000;97:8566-8571.
93. Welch PJ, Marcusson EG, Li QX, et al. Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes. Genomics. 2000;66:274-283.
94. Li QX, Robbins JM, Welch PJ, Wong-Staal F, Barber JR. A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation. Nucleic Acids Res. 2000;28:2605-2612.
95. Kato Y, Tsunemi M, Miyagishi M, Kawasaki H, Taira K. Functional gene discovery using hybrid ribozyme libraries. Methods Mol Biol. 2004;252:245-256.
96. Kawasaki H, Taira K. Identification of genes by hybrid ribozymes that couple cleavage activity with the unwinding activity of an endogenous RNA helicase. EMBO Rep. 2002;3:443-450.
97. Kawasaki H, Onuki R, Suyama E, Taira K. Identification of genes that function in the TNF-alpha-mediated apoptotic pathway using randomized hybrid ribozyme libraries. Nat Biotechnol. 2002;20:376-380.
98. Kawasaki H, Tsunemi M, Iyo M, et al. A functional gene discovery in cell differentiation by hybrid ribozyme and siRNA libraries. Nucleic Acids Res Suppl. 2002;2:275-276.
99. Suyama E, Kawasaki H, Nakajima M, Taira K. Identification of genes involved in cell invasion by using a library of randomized hybrid ribozymes. Proc Natl Acad Sci U S A. 2003;100:5616-5621.
100. Suyama E, Kawasaki H, Kasaoka T, Taira K. Identification of genes responsible for cell migration by a library of randomized ribozymes. Cancer Res. 2003;63:119-124.
101. Onuki R, Bando Y, Suyama E, et al. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 2004;23:959-968.
102. Rhoades K, Wong-Staal F. Inverse Genomics as a powerful tool to identify novel targets for the treatment of neurodegenerative diseases. Mech Ageing Dev. 2003;124:125-132.
103. McCarroll SA, Murphy CT, Zou S, et al. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat Genet. 2004;36:197-204.
104. Ida H, Boylan SA, Weigel AL, Hjelmeland LM. Age-related changes in the transcriptional profile of mouse RPE/choroid. Physiol Genomics. 2003;15:258-262.
105. Lau KM, Tam NN, Thompson C, Cheng RY, Leung YK, Ho SM. Age-associated changes in histology and gene-expression profile in the rat ventral prostate. Lab Invest. 2003;83:743-757.
106. Balasubramaniam J, Del Bigio MR. Analysis of age-dependant alteration in the brain gene expression profile following induction of hydrocephalus in rats. Exp Neurol. 2002;173:105-113.
107. Juhasz O, Zhu Y, Garg R, Anisimov SV, Boheler KR. Analysis of altered genomic expression profiles in the senescent and diseased myocardium using cDNA microarrays. Eur J Heart Fail. 2002;4:687-697.
108. Dhahbi JM, Kim HJ, Mote PL, Beaver RJ, Spindler SR. Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci U S A. 2004;101:5524-5529.
109. Lee J, Nam S, Hwang SB, et al. Functional genomic approaches using the nematode Caenorhabditis elegans as a model system. J Biochem Mol Biol. 2004;37:107-113.
110. Szekely AM, Chen YH, Zhang C, Oshima J, Weissman SM. Werner protein recruits DNA polymerase delta to the nucleolus. Proc Natl Acad Sci U S A. 2000;97:11365-11370.
111. Lim CS, Park ES, Kim DJ, et al. SPIN90 (SH3 protein interacting with Nck, 90 kDa), an adaptor protein that is developmentally regulated during cardiac myocyte differentiation. J Biol Chem. 2001;276: 12871-12878.
112. Nguyen DT, Rovira, II, Finkel T. Regulation of the Werner helicase through a direct interaction with a subunit of protein kinase A. FEBS Lett. 2002;521:170-174.
113. Sato K, Yomogida K, Wada T, et al. Type XXVI collagen, a new member of the collagen family, is specifically expressed in the testis and ovary. J Biol Chem. 2002;277:37678-37684.
114. Chatterton JE, Hu X, Wong-Staal F. Ribozymes in gene identification, target validation and drug discovery. DDT: Targets. 2004;3:10-16.
115. Jenison RD, Jennings SD, Walker DW, Bargatze RF, Parma D. Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion. Antisense Nucleic Acid Drug Dev. 1998;8:265-279.
116. Hicke BJ, Watson SR, Koenig A, et al. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. Clin Invest. 1996;98:2688-2692.
117. Wang C, Zhang M, Yang G, et al. Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol. 2003; 102:15-22.
118. Hicke BJ, Marion C, Chang YF, et al. Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem. 2001; 276:48644-48654.
119. Kusser W. Chemically modified nucleic acid aptamers for in vitro selections: evolving evolution. J Biotechnol. 2000;74:27-38.
120. Famulok M, Mayer G. Aptamers as tools in molecular biology and immunology. Curr Top Microbiol Immunol. 1999;243:123-136.
121. Conrad RC, Baskerville S, Ellington AD. In vitro selection methodologies to probe RNA function and structure. Mol Divers. 1995;1:69-78.
122. Golden MC, Collins BD, Willis MC, Koch TH. Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. J. Biotechnol. 2000;81: 167-178.
123. Willis MC, Collins BD, Zhang T, et al. Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem. 1998;9:573-582.
124. Famulok M, Blind M, Mayer G. Intramers as promising new tools in functional proteomics. Chem Biol. 2001;8:931-939.
125. Mayer G, Blind M, Nagel W, et al. Controlling small guaninenucleotide- exchange factor function through cytoplasmic RNA intramers. Proc Natl Acad Sci U S A. 2001;98:4961-4965.
126. Fang X, Cao Z, Beck T, Tan W. Molecular aptamer for real-time oncoprotein platelet-derived growth factor monitoring by fluorescence anisotropy. Anal Chem. 2001;73:5752-5757.
127. Nutiu R, Li Y. Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling. Chemistry. 2004; 10:1868-1876.
128. McCauley TG, Hamaguchi N, Stanton M. Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Anal Biochem. 2003;319:244-250.
129. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806-811.
130. Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 2000;101:25-33.
131. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 2001;20:6877-6888.
132. Wang QC, Nie QH, Feng ZH. RNA interference: antiviral weapon and beyond. World J Gastroenterol. 2003;9:1657-1661.
133. Arenz C, Schepers U. RNA interference: from an ancient mechanism to a state of the art therapeutic application? Naturwissenschaften. 2003;90:345-359.
134. Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev. 2003;67:657-685.
135. Timmons L, Court DL, Fire A. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene. 2001;263:103-112.
136. Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2001;2:20.
137. Asencio C, Rodriguez-Aguilera JC, Ruiz-Ferrer M, Vela J, Navas P. Silencing of ubiquinone biosynthesis genes extends life span in Caenorhabditis elegans. FASEB J. 2003;17:1135-1137.
138. Ashrafi K, Chang FY, Watts JL, et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature. 2003;421:268-272.
139. Lee SS, Kennedy S, Tolonen AC, Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science. 2003;300: 644-647.
140. Bartke A, Chandrashekar V, Bailey B, Zaczek D, Turyn D. Consequences of growth hormone (GH) overexpression and GH resistance. Neuropeptides. 2002;36:201-208.
141. Stein P, Svoboda P, Anger M, Schultz RM. RNAi: mammalian oocytes do it without RNA-dependent RNA polymerase. RNA. 2003; 9:187-192.
142. Svoboda P, Stein P, Anger M, Bernstein E, Hannon GJ, Schultz RM. RNAi and expression of retrotransposons MuERV-L and IAP in preimplantation mouse embryos. Dev Biol. 2004;269:276-285.
143. Gil J, Esteban M. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis. 2000. 2000;5: 107-114.
144. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494-498.
145. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002;26:199-213.
146. Kong XC, Barzaghi P, Ruegg MA. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep. 2004;5: 183-188.
147. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol. 2003;327: 761-766.
148. Matsuda T, Cepko CL. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Natl Acad Sci U S A. 2004;101: 16-22.
149. Paddison PJ, Silva JM, Conklin DS, et al. A resource for large-scale RNA-interference-based screens in mammals. Nature. 2004;428:427-431.
150. Miyagishi M, Taira K. Strategies for generation of an siRNA expression library directed against the human genome. Oligonucleotides. 2003;13:325-333.
151. Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature. 2004;428:431-437.
152. Zheng L, Liu J, Batalov S, et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc Natl Acad Sci U S A. 2004;101:135-140.
153. Shirane D, Sugao K, Namiki S, Tanabe M, Iino M, Hirose K. Enzymatic production of RNAi libraries from cDNAs. Nat Genet. 2004;36:190-196.
154. Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs. Genes Dev. 2003;17:438-442.
155. Zeng Y, Cullen BR. RNA interference in human cells is restricted to the cytoplasm. RNA. 2002;8:855-860.
156. Hutvagner G, Zamore PD. A microRNA in a multiple-remover RNAi enzyme complex. Science. 2002;297:2056-2060.
157. Schwarz DS, Hutvagner G, Haley B, Zamore PD. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell. 2002;10:537-548.
158. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003;115:199-208.
159. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol. 2004;22:326-330.
160. Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol. 2002;20:497-500.
161. Miyagishi M, Taira K. RNAi Expression Vectors in Mammalian Cells. Meth Mol Biol. 2004;252:483-492.
162. Hohjoh H. Enhancement of RNAi activity by improved siRNA duplexes. FEBS Lett. 2004;557:193-198.
163. Wang L, Mu FY. A Web-based design center for vector-based siRNA and siRNA cassette. Bioinformatics. 2004;4:4.
164. Duxbury MS, Whang EE. RNA interference: a practical approach. J Surg Res. 2004;117:339-344.
165. Garigan D, Hsu AL, Fraser AG, Kamath RS, Ahringer J, Kenyon C. Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics. 2002;161: 1101-1112.
166. Walker GA, Thompson FJ, Brawley A, Scanlon T, Devaney E. Heat shock factor functions at the convergence of the stress response and developmental pathways in Caenorhabditis elegans. FASEB J. 2003; 17:1960-1962.
167. Lim CS, Mian IS, Demburg AF, Campisi J. C. elegans clk-2, a gene that limits life span, encodes a telomere length regulator similar to yeast telomere binding protein Te12p. Curr Biol. 2001;11:1706-1710.
168. Nehrke K. A reduction in intestinal cell pHi due to loss of the Caenorhabditis elegans Na+/H+ exchanger NHX-2 increases life span. J Biol Chem. 2003;278:44657-44666.
169. Morozova N, Forry EP, Shahid E, et al. Antioxidant function of a novel selenoprotein in Drosophila melanogaster. Genes Cells. 2003; 8:963-971.
170. Allikian MJ, Deckert-Cruz D, Rose MR, Landis GN, Tower J. Doxycycline-induced expression of sense and inverted-repeat constructs modulates phosphogluconate mutase (Pgm) gene expression in adult Drosophila melanogaster. Genome Biol. 2002;3:15.
171. Blander G, de Oliveira RM, Conboy CM, Haigis M, Guarente L. Superoxide dismutase 1 knock-down induces senescence in human fibroblasts. J Biol Chem. 2003;278:38966-38969.
172. Kirby K, Hu J, Hilliker AJ, Phillips JP. RNA interference-mediated silencing of Sod2 in Drosophila leads to early adult-onset mortality and elevated endogenous oxidative stress. Proc Natl Acad Sci U S A. 2002;99:16162-16167.
173. Oruetxebarria I, Venturini F, Kekarainen T, et al. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. J Biol Chem. 2004;279:3807-3816.
174. Grandori C, Wu KJ, Fernandez P, et al. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev. 2003;17:1569-1574.
175. Zou X, Ray D, Aziyu A, et al. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes Dev. 2002;16:2923-2934.
176. Dirac AM, Bernards R. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J Biol Chem. 2003;278:11731-11734.
177. Thomas MK, Devon ON, Lee JH, et al. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest. 2001;108:319-329.
178. Wan MS, Fell PL, Akhtar S. Synthetic 2′-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity. Antisense Nucleic Acid Drug Dev. 1998;8:309-317.
179. Musio A, Montagna C, Zambroni D, et al. Inhibition of BUB1 results in genomic instability and anchorage-independent growth of normal human fibroblasts. Cancer Res. 2003;63:2855-2863.
180. Nylandsted J, Rohde M, Bartek J, Strauss M. Expression of a p161NK4a-specific ribozyme downmodulates p161NK4a abundance and accelerates cell proliferation. FEBS Lett. 1998;436:41-45.
181. Rouault JP, Kuwabara PE, Sinilnikova OM, Duret L, Thierry-Mieg D, Billaud M. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr Biol. 1999;9:329-332.
182. Dillin A, Crawford DK, Kenyon C. Timing requirements for insulin/IGF-1 signaling in C. elegans. Science. 2002;298:830-834.
183. Murakami S, Salmon A, Miller RA. Multiplex stress resistance in cells from long-lived dwarf mice. FASEB J. 2003;17:1565-1566.
184. Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet. 2003;33:40-48.
185. Dillin A, Hsu AL, Arantes-Oliveira N, et al. Rates of behavior and aging specified by mitochondrial function during development. Science. 2002;298:2398-2401.
186. Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science. 2003;301:1387-1391.
187. Hertel KJ, Pardi A, Uhlenbeck OC, et al. Numbering system for the hammerhead. Nucleic Acids Res. 1992;20:3252.
188. Pyle AM. Metal ions in the structure and function of RNA. J Biol Inorg Chem. 2002;7:679-690.
189. Donahue CP, Yadava RS, Nesbitt SM, Fedor MJ. The kinetic mechanism of the hairpin ribozyme in vivo: influence of RNA helix stability on intracellular cleavage kinetics. J Mol Biol. 2000;295:693-707.
190. Puerta-Femandez E, Romero-Lopez C, Barroso-del Jesus A, Berzal-Herranz A. Ribozymes: recent advances in the development of RNA tools. FEMS Microbiol Rev. 2003;27:75-97.